Literature DB >> 9101123

Thrombin receptor antagonists: a work in progress.

L F Brass1.   

Abstract

The thrombin receptor and protease-activated receptor 2 (PAR-2) are the two currently known members of the large family of G protein-coupled receptors that are activated by proteases. Both receptors are located on cells in and around the vascular space, including platelets, endothelial cells, vascular smooth muscle cells, fibroblasts and some lymphocytes. This brief review summarizes current information on thrombin receptors and focuses on some of the issues that are relevant for ongoing efforts to develop thrombin receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101123     DOI: 10.1097/00019501-199701000-00008

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  3 in total

1.  Reversible and irreversible intracellular Ca2+ spiking in single isolated human platelets.

Authors:  J F Hussain; M P Mahaut-Smith
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

2.  Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.

Authors:  H Andersen; D L Greenberg; K Fujikawa; W Xu; D W Chung; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.

Authors:  D C Howell; N R Goldsack; R P Marshall; R J McAnulty; R Starke; G Purdy; G J Laurent; R C Chambers
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.